NDC 83939-0022-01 - Oxybutynin Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83939-0022
- Requested NDC
- 83939-0022-01
- Package NDCs from labels
- 83939-0022-1, 83939-0022-2, 83939-0022-3, 83939-0022-01
- Manufacturer
- VERITYRX, LLC
- Effective date
- 2025-10-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxybutynin Chloride - VERITYRX, LLC | VERITYRX, LLC | 2025-10-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83939-0022-1 | Oxybutynin Chloride | 1 in 1 POUCH | TABLET | 1 | 1 | |
| 83939-0022-2 | Oxybutynin Chloride | 1 in 1 POUCH | TABLET | 1 | 1 | |
| 83939-0022-2 | Oxybutynin Chloride | 50 in 1 BOX, UNIT-DOSE | TABLET | 50 | 1 | |
| 83939-0022-3 | Oxybutynin Chloride | 1 in 1 POUCH | TABLET | 1 | 1 | |
| 83939-0022-3 | Oxybutynin Chloride | 100 in 1 BOX, UNIT-DOSE | TABLET | 100 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| oxybutynin | OXYBUTYNIN | NCS HealthCare of KY, LLC dba Vangard Labs | ed10f0c9-23d6-4ded-b17f-ed474632a965 | 2024-08-12 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | f26e590d-956e-493b-a6ac-6056aeeaf411 | 2024-08-09 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | RISING PHARMA HOLDINGS, INC. | f8ed80f2-6c3d-4d7f-b761-c2447973c1f9 | 2024-07-03 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 7593becc-250f-4d25-8401-a9f72f3f5ad4 | 2024-06-03 | Warnings, Adverse reactions | L9F3D9RENQ |
| oxybutynin chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 8f147f73-cfc6-40a3-b1a3-e4cab1868523 | 2024-06-03 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 39a2d144-0c10-4aec-9fa4-0adc24b332eb | 2024-06-03 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | 169d6d58-8887-4bdd-95bd-873d1f049eaa | 2024-05-24 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Proficient Rx LP | 7d2332b4-9e48-4bb2-a2c3-75e16e1d455b | 2024-04-01 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Bryant Ranch Prepack | 2f898b29-46cf-4427-bb64-8c30532222f5 | 2024-01-18 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 5e3b454b-6d3c-418b-8ac2-b0e17f018bbf | 2023-12-27 | Warnings, Adverse reactions | ANDA209823 863664 L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | afc6a3aa-e43d-4f10-bdbd-570a149bf9db | 2023-12-27 | Warnings, Adverse reactions | ANDA209823 863664 L9F3D9RENQ |
| oxybutynin | OXYBUTYNIN | Zydus Pharmaceuticals USA Inc. | c042bf06-79a3-4dc7-ae05-3ef3cfae9d44 | 2023-11-07 | Warnings, Adverse reactions | L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | A-S Medication Solutions | 83522acd-0ecc-46ac-a018-a3205ba096ff | 2023-11-01 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 5b72d34e-ae57-4459-ba2c-3bae8a69c5c1 | 2023-10-04 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 02ff3be7-fc5c-4b91-8c67-ecdf6e19c42a | 2023-05-31 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | d2bb6927-5fbf-49ca-a891-d701bff1c812 | 2023-05-31 | Warnings, Adverse reactions | ANDA209823 863664 L9F3D9RENQ |
| Oxybutynin Chloride Extended Release | OXYBUTYNIN CHLORIDE | Lannett Company, Inc. | c5950dba-d92b-46a0-993f-af9f9ddb52bf | 2023-05-30 | Warnings, Adverse reactions | L9F3D9RENQ |
| oxybutynin | OXYBUTYNIN | A-S Medication Solutions | 1f95920c-5dc2-44e4-b61d-b2c5e05390ba | 2023-02-06 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Amneal Pharmaceuticals LLC | 53924eba-1919-4203-9a1e-d57dfdd3b963 | 2023-02-02 | Warnings, Adverse reactions | L9F3D9RENQ |
| Oxybutynin Chloride | OXYBUTYNIN CHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 1e1c1043-e4c5-4a06-9cc1-45d4397746f4 | 2023-01-04 | Warnings, Adverse reactions | 863664 L9F3D9RENQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.